Hexavest’s AstraZeneca AZN Stock Holding History

Hexavest’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-273	Closed	-$24K	–	433
2019 Q3	$24K	Hold	273	–	–	﹤0.01%	377
2019 Q2	$22K	Hold	273	–	–	﹤0.01%	393
2019 Q1	$22K	Hold	273	–	–	﹤0.01%	360
2018 Q4	$21K	Hold	273	–	–	﹤0.01%	333
2018 Q3	$22K	Hold	273	–	–	﹤0.01%	378
2018 Q2	$19K	Hold	273	–	–	﹤0.01%	390
2018 Q1	$19K	Hold	273	–	–	﹤0.01%	427
2017 Q4	$19K	Hold	273	–	–	﹤0.01%	445
2017 Q3	$18K	Hold	273	–	–	﹤0.01%	444
2017 Q2	$19K	Hold	273	–	–	﹤0.01%	441
2017 Q1	$17K	Hold	273	–	–	﹤0.01%	446
2016 Q4	$15K	Hold	273	–	–	﹤0.01%	450
2016 Q3	$18K	Hold	273	–	–	﹤0.01%	449
2016 Q2	$16K	Hold	273	–	–	﹤0.01%	460
2016 Q1	$15K	Hold	273	–	–	﹤0.01%	458
2015 Q4	$19K	Hold	273	–	–	﹤0.01%	438
2015 Q3	$17K	Sell	273 -272	-50%	-$17.9K	﹤0.01%	441
2015 Q2	$35K	Hold	545	–	–	﹤0.01%	403
2015 Q1	$37K	Hold	545	–	–	﹤0.01%	388
2014 Q4	$38K	Hold	545	–	–	﹤0.01%	381
2014 Q3	$39K	Hold	545	–	–	﹤0.01%	384
2014 Q2	$40K	Hold	545	–	–	﹤0.01%	377
2014 Q1	$35K	Hold	545	–	–	﹤0.01%	377
2013 Q4	$32K	Hold	545	–	–	﹤0.01%	327
2013 Q3	$28K	Hold	545	–	–	﹤0.01%	345
2013 Q2	$26K	Buy	+545	New	+$27.8K	﹤0.01%	345

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hexavest's AZN Position: Q4 2019 in Review

Hexavest sold out of AstraZeneca (AZN) in Q4 2019, closing a stake of 273 shares — an estimated $24K sold.

Hexavest first reported a position in AZN in Q2 2013 and held it in 26 quarters. The position peaked at $40K in Q2 2014. 634 funds tracked by Wall St. Rank hold AZN as of Q4 2019.

Hexavest reported no remaining AstraZeneca position as of Q4 2019 after selling out during the quarter.
Hexavest sold 273 AstraZeneca shares in Q4 2019, an estimated $24K.
Hexavest first reported a position in AstraZeneca in Q2 2013 and held it in 26 quarters.
Hexavest's AstraZeneca position peaked at $40K in Q2 2014.
634 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2019.

Based on Hexavest's 13F filing for Q4 2019, filed 9 Jan 2020.